{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:24:02Z","timestamp":1792794242855,"version":"4.5.0"},"reference-count":74,"publisher":"Oxford University Press (OUP)","issue":"suppl_2","license":[{"start":{"date-parts":[[2018,3,4]],"date-time":"2018-03-04T00:00:00Z","timestamp":1520121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/legalcode"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["098316"],"award-info":[{"award-number":["098316"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"South African Research Chairs Initiative of the Department of Science and Technology","id":[{"id":"https:\/\/ror.org\/048kh7197","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Research Foundation of South Africa","award":["64787"],"award-info":[{"award-number":["64787"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI 045008"],"award-info":[{"award-number":["P30 AI 045008"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,4]]},"DOI":"10.1093\/cid\/cix1143","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T00:29:08Z","timestamp":1515112148000},"page":"S152-S159","source":"Crossref","is-referenced-by-count":102,"title":["CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis"],"prefix":"10.1093","volume":"66","author":[{"given":"Nathan","family":"Ford","sequence":"first","affiliation":[{"name":"HIV Department, World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zara","family":"Shubber","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, Imperial College London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph N","family":"Jarvis","sequence":"additional","affiliation":[{"name":"Botswana-UPenn Partnership, Gaborone, Botswana"},{"name":"Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana"},{"name":"Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Chiller","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Greene","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Migone","sequence":"additional","affiliation":[{"name":"HIV Department, World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Vitoria","sequence":"additional","affiliation":[{"name":"HIV Department, World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg","family":"Doherty","sequence":"additional","affiliation":[{"name":"HIV Department, World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Meintjes","sequence":"additional","affiliation":[{"name":"Wellcome Trust Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine South Africa"},{"name":"Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,4]]},"reference":[{"key":"key\n\t\t\t\t20180626045900_CIT0001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2016.167","article-title":"Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy","volume":"13","author":"Williamson","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"key\n\t\t\t\t20180626045900_CIT0002","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180626045900_CIT0003","volume":"16","author":"French","year":"2002","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180626045900_CIT0004","doi-asserted-by":"crossref","first-page":"e69288","DOI":"10.1371\/journal.pone.0069288","article-title":"Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa","volume":"8","author":"Jarvis","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626045900_CIT0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells\/microL who start HIV therapy in resource-limited settings","volume":"51","author":"Meya","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180626045900_CIT0006","doi-asserted-by":"crossref","first-page":"e62213","DOI":"10.1371\/journal.pone.0062213","article-title":"Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program\u2014Vietnam","volume":"8","author":"Smith","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626045900_CIT0007","doi-asserted-by":"crossref","first-page":"e0171917","DOI":"10.1371\/journal.pone.0171917","article-title":"The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: findings from a randomised trial evaluating different health care strategies","volume":"12","author":"Kimaro","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626045900_CIT0008","author":"World Health Organization","year":"2017"},{"key":"key\n\t\t\t\t20180626045900_CIT0009","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/tmi.12790","article-title":"Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in S\u00e3o Paulo, Brazil","volume":"21","author":"Vidal","year":"2016","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20180626045900_CIT0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/QAI.0000000000001048","article-title":"Brief report: geographical variation in prevalence of cryptococcal antigenemia among HIV-infected, treatment-naive patients in Nigeria: a multicenter cross-sectional study","volume":"73","author":"Ezeanolue","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180626045900_CIT0011","doi-asserted-by":"crossref","first-page":"ofv046","DOI":"10.1093\/ofid\/ofv046","article-title":"Cryptococcal antigenemia in immunocompromised human immunodeficiency virus patients in rural Tanzania: a preventable cause of early mortality","volume":"2","author":"Letang","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"key\n\t\t\t\t20180626045900_CIT0012","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.mycmed.2016.08.007","article-title":"Prevalence and factors associated with cryptococcal antigenemia in HIV-infected patients in Cotonou\/Benin [in French]","volume":"26","author":"Ogouy\u00e8mi-Hounto","year":"2016","journal-title":"J Mycol Med"},{"key":"key\n\t\t\t\t20180626045900_CIT0013","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180626045900_CIT0014","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180626045900_CIT0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/096228029300200202","article-title":"The statistical basis of meta-analysis","volume":"2","author":"Fleiss","year":"1993","journal-title":"Stat Methods Med Res"},{"key":"key\n\t\t\t\t20180626045900_CIT0016","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1214\/aoms\/1177729756","article-title":"Transformations related to the angular and the square root","volume":"21","author":"Freeman","year":"1950","journal-title":"Ann Math Stat"},{"key":"key\n\t\t\t\t20180626045900_CIT0017","first-page":"138","article-title":"The inverse of the Freeman-Tukey double arcsine transformation","volume":"32","author":"Miller","year":"1978","journal-title":"Am Stat"},{"key":"key\n\t\t\t\t20180626045900_CIT0018","article-title":"Infectious and noninfectious multimorbidity among HIV clinic clients in the African Cohort Study [abstract 764]. Conference on Retroviruses and Opportunistic Infections, Seattle, 23-26 February 2015","author":"AkeMaswaiKiweewa"},{"key":"key\n\t\t\t\t20180626045900_CIT0019","doi-asserted-by":"crossref","first-page":"e58377","DOI":"10.1371\/journal.pone.0058377","article-title":"High prevalence of cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia","volume":"8","author":"Alemu","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626045900_CIT0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/QAI.0b013e3182926f95","article-title":"Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda","volume":"63","author":"Andama","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180626045900_CIT0021","first-page":"14","article-title":"Asymptomatic cryptococcal antigenemia in people living with HIV (PLHIV) with severe immunosuppression: is routine CrAg screening indicated in India","volume":"65","author":"Anuradha","year":"2017","journal-title":"J Assoc Physicians India"},{"key":"key\n\t\t\t\t20180626045900_CIT0022","doi-asserted-by":"crossref","first-page":"e39347","DOI":"10.1371\/journal.pone.0039347","article-title":"High prevalence of tuberculosis and serious bloodstream infections in ambulatory individuals presenting for antiretroviral therapy in Malawi","volume":"7","author":"Bedell","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626045900_CIT0023","doi-asserted-by":"crossref","first-page":"e75585","DOI":"10.1371\/journal.pone.0075585","article-title":"Comparison of cryptococcal antigenemia between antiretroviral na\u00efve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia","volume":"8","author":"Beyene","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626045900_CIT0024","article-title":"Integrated cryptococcal antigen screening and pre-emptive treatment prior to initiation of antiretroviral treatment in HIV-infected adults in Cambodia","author":"Chim","year":"2013"},{"key":"key\n\t\t\t\t20180626045900_CIT0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/2325957415592475","article-title":"Feasibility and acceptability of cryptococcal antigen screening and prevalence of cryptocococcemia in patients attending a resource-limited HIV\/AIDS clinic in Malawi","volume":"14","author":"Chipungu","year":"2015","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"key\n\t\t\t\t20180626045900_CIT0026","volume-title":"Maximizing detection and improving outcomes of cryptococcosis in rural Tanzania","author":"Faini"},{"key":"key\n\t\t\t\t20180626045900_CIT0027","doi-asserted-by":"crossref","first-page":"e0178721","DOI":"10.1371\/journal.pone.0178721","article-title":"Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay","volume":"12","author":"Frola","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626045900_CIT0028","doi-asserted-by":"crossref","first-page":"18821","DOI":"10.7448\/IAS.17.1.18821","article-title":"Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia","volume":"17","author":"Ganiem","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20180626045900_CIT0029","volume-title":"Use of a rapid test for the diagnosis of cryptococcosis in an HIV positive adult population in the city of Popay\u00e1n, Colombia","author":"Gonzalez"},{"key":"key\n\t\t\t\t20180626045900_CIT0030","volume-title":"Evaluation of reflex laboratory cryptococcal disease screening","author":"Govender","year":"2012\u20132015"},{"key":"key\n\t\t\t\t20180626045900_CIT0031","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/hiv.12245","article-title":"Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa","volume":"16","author":"Govender","year":"2015","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20180626045900_CIT0032","volume-title":"Routine cryptococcal antigen screening before ART initiation: a study from an ART center of Eastern India","author":"Guha","year":"2015"},{"key":"key\n\t\t\t\t20180626045900_CIT0033","first-page":"119","article-title":"Prevalence of cryptococcal antigen positivity among HIV infected patient with CD4 cell count less than 100 of Imam Khomeini Hospital, Tehran, Iran","volume":"9","author":"Hajiabdolbaghi","year":"2017","journal-title":"Iranian J Microbiol"},{"key":"key\n\t\t\t\t20180626045900_CIT0034","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/597262","article-title":"Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa","volume":"48","author":"Jarvis","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180626045900_CIT0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/ijmm.IJMM_15_596","article-title":"High prevalence of cryptococcal antigenaemia amongst asymptomatic advanced HIV patients in Pune, India","volume":"35","author":"Kadam","year":"2017","journal-title":"Indian J Med Microbiol"},{"key":"key\n\t\t\t\t20180626045900_CIT0036","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jinf.2015.01.011","article-title":"Cryptococcosis in HIV-infected hospitalized patients in Germany: evidence for routine antigen testing","volume":"71","author":"Katchanov","year":"2015","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20180626045900_CIT0037","volume-title":"The invisible killer: a pilot project on cryptococcal meningitis screening, diagnosis and management in high volume hospitals in Ethiopia","author":"Kebede"},{"key":"key\n\t\t\t\t20180626045900_CIT0038","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/2325957413500533","article-title":"Utility of cryptococcal antigen screening and evolution of asymptomatic cryptococcal antigenemia among HIV-infected women starting antiretroviral therapy in Thailand","volume":"13","author":"Kwan","year":"2014","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"key\n\t\t\t\t20180626045900_CIT0039","doi-asserted-by":"crossref","first-page":"e103156","DOI":"10.1371\/journal.pone.0103156","article-title":"Performance of cryptococcal antigen lateral flow assay using saliva in Ugandans with CD4 <100","volume":"9","author":"Kwizera","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626045900_CIT0040","volume-title":"Prevalence of advanced HIV disease and cryptococcal infection in Gaborone, Botswana","author":"Lechiile","year":"2017"},{"key":"key\n\t\t\t\t20180626045900_CIT0041","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-3156.2007.01874.x","article-title":"Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda","volume":"12","author":"Liechty","year":"2007","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20180626045900_CIT0042","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/cid\/civ936","article-title":"Cryptococcal antigen screening in patients initiating ART in South Africa: a prospective cohort study","volume":"62","author":"Longley","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180626045900_CIT0043","volume-title":"Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: a feasibility study in rural Lesotho","author":"Luzinda"},{"key":"key\n\t\t\t\t20180626045900_CIT0044","doi-asserted-by":"crossref","first-page":"19040","DOI":"10.7448\/IAS.17.1.19040","article-title":"Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, Tanzania","volume":"17","author":"Magambo","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20180626045900_CIT0045","volume-title":"High prevalence of CNS dissemination with asymptomatic cryptococcal antigenemia","author":"Makadzange"},{"key":"key\n\t\t\t\t20180626045900_CIT0046","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-3156.2010.02683.x","article-title":"Short communication: low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana","volume":"16","author":"Mamoojee","year":"2011","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20180626045900_CIT0047","doi-asserted-by":"crossref","first-page":"786","DOI":"10.4269\/ajtmh.15-0857","article-title":"Point-of-care testing for cryptococcal disease among hospitalized human immunodeficiency virus-infected adults in Ethiopia","volume":"95","author":"Mamuye","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180626045900_CIT0048","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/cid\/ciu937","article-title":"Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986\u20132012","volume":"60","author":"McKenney","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180626045900_CIT0049","volume-title":"Lateral flow assay in the early diagnosis of cryptococcosis in severely immunosupressed AIDS-patients from the Midwest Region of Brazil","author":"Mendes"},{"key":"key\n\t\t\t\t20180626045900_CIT0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40475-015-0045-z","article-title":"Preventing cryptococcosis-shifting the paradigm in the era of highly active antiretroviral therapy","volume":"2","author":"Meya","year":"2015","journal-title":"Curr Trop Med Rep"},{"key":"key\n\t\t\t\t20180626045900_CIT0051","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/tmi.12067","article-title":"The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in Kenya","volume":"18","author":"Meyer","year":"2013","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20180626045900_CIT0052","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial","volume":"385","author":"Mfinanga","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180626045900_CIT0053","volume-title":"A cross-sectional laboratory survey to determine the prevalence of cryptococcal antigenaemia in South Africa","author":"Mhlanga","year":"2015"},{"key":"key\n\t\t\t\t20180626045900_CIT0054","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/QAI.0b013e31811ed32c","article-title":"Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients","volume":"45","author":"Micol","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180626045900_CIT0055","volume-title":"Pre-ART cryptococcal antigen titer associated with preemptive fluconazole failure","author":"Morawski","year":"2016"},{"key":"key\n\t\t\t\t20180626045900_CIT0056","volume-title":"Mycobacterium tuberculosis lateral flow urine lipoarabinomannan assay (TBLAM) and cryptococcal antigen lateral flow assay (CrAg LFA) as screening among patients with advanced HIV-disease in Conakry, Guinea","author":"Ndayisenga","year":"2017"},{"key":"key\n\t\t\t\t20180626045900_CIT0057","doi-asserted-by":"crossref","first-page":"ofw055","DOI":"10.1093\/ofid\/ofw055","article-title":"Cryptococcal antigenemia in Nigerian patients with advanced human immunodeficiency virus: influence of antiretroviral therapy adherence","volume":"3","author":"Oladele","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"key\n\t\t\t\t20180626045900_CIT0058","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5001\/omj.2012.51","article-title":"Screening for cryptococcal antigenemia in anti-retroviral na\u00efve AIDS patients in Benin City, Nigeria","volume":"27","author":"Osazuwa","year":"2012","journal-title":"Oman Med J"},{"key":"key\n\t\t\t\t20180626045900_CIT0059","doi-asserted-by":"crossref","first-page":"18003","DOI":"10.7448\/IAS.15.2.18003","article-title":"Response to comment on \u201cprevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda\u201d","volume":"15","author":"Oyella","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20180626045900_CIT0060","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1097\/QAI.0000000000000527","article-title":"Implementation and operational research: integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia","volume":"68","author":"Pac","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180626045900_CIT0061","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jinf.2012.09.014","article-title":"The prevalence of cryptococcal antigenemia in newly diagnosed HIV patients in a southwest London cohort","volume":"66","author":"Patel","year":"2013","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20180626045900_CIT0062","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jinf.2010.03.015","article-title":"The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts","volume":"60","author":"Pongsai","year":"2010","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20180626045900_CIT0063","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1186\/s13104-015-1707-6","article-title":"Screening for cryptococcal antigenemia using the lateral flow assay in antiretroviral therapy-na\u00efve HIV-positive adults at an Ethiopian hospital clinic","volume":"8","author":"Reepalu","year":"2015","journal-title":"BMC Res Notes"},{"key":"key\n\t\t\t\t20180626045900_CIT0064","doi-asserted-by":"crossref","first-page":"e0183656","DOI":"10.1371\/journal.pone.0183656","article-title":"Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: a feasibility study in rural Lesotho","volume":"12","author":"Rick","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626045900_CIT0065","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/tmi.12157","article-title":"Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay","volume":"18","author":"Rugemalila","year":"2013","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20180626045900_CIT0066","doi-asserted-by":"crossref","first-page":"e0161830","DOI":"10.1371\/journal.pone.0161830","article-title":"Estimated prevalence of Cryptococcus antigenemia (CrAg) among HIV-infected adults with advanced immunosuppression in Namibia justifies routine screening and preemptive treatment","volume":"11","author":"Sawadogo","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626045900_CIT0067","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00126334-200307010-00019","article-title":"Systematic screening of cryptococcal antigenemia in HIV-positive adults in Uganda","volume":"33","author":"Tassie","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180626045900_CIT0068","volume-title":"Prevalence of latent cryptococcosis among HIV-infected patients in Cameroon: the ANRS 12312 PreCASA study","author":"Temfack"},{"key":"key\n\t\t\t\t20180626045900_CIT0069","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1097\/QAI.0000000000000976","article-title":"Implementation and operational research: evaluation of a public-sector, provider-initiated cryptococcal antigen screening and treatment program, Western Cape, South Africa","volume":"72","author":"Vallabhaneni","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180626045900_CIT0070","volume-title":"Cryptoccal antigen screening among patients with advanced HIV infection in Vietnam","author":"Vu","year":"2016"},{"key":"key\n\t\t\t\t20180626045900_CIT0071","doi-asserted-by":"crossref","first-page":"e85698","DOI":"10.1371\/journal.pone.0085698","article-title":"No association of cryptococcal antigenemia with poor outcomes among antiretroviral therapy-experienced HIV-infected patients in Addis Ababa, Ethiopia","volume":"9","author":"Smitson","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626045900_CIT0072","doi-asserted-by":"crossref","first-page":"e101459","DOI":"10.1371\/journal.pone.0101459","article-title":"Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda","volume":"9","author":"Manabe","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626045900_CIT0073","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1093\/cid\/cix1140","article-title":"Community CD4 count as a proxy for ongoing morbidity and mortality risk over 10 years of increasing antiretroviral therapy coverage in South Africa","volume":"66","author":"Osler","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180626045900_CIT0074","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1093\/cid\/ciy045","article-title":"Persistent high burden of advanced human immunodeficiency virus (HIV) disease among patients seeking care in South Africa\u2019s national HIV program: data from a nationwide laboratory cohort","volume":"66","author":"Carmona","year":"2018","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/66\/suppl_2\/S152\/25084524\/cix1143.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T04:45:13Z","timestamp":1719722713000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/66\/suppl_2\/S152\/4918992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,4]]},"references-count":74,"journal-issue":{"issue":"suppl_2","published-online":{"date-parts":[[2018,3,4]]},"published-print":{"date-parts":[[2018,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix1143","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4,1]]},"published":{"date-parts":[[2018,3,4]]}}}